123 related articles for article (PubMed ID: 37904484)
1. Associations of ITPA gene polymorphisms with outcomes among chronic hepatitis C patients treated with Peg-interferon/ribavirin: A 5-year follow-up study.
Liu Z; Wang Y; Li H; Wang X; Wang X; Xu X; Ma C; Wang J
Medicine (Baltimore); 2023 Oct; 102(43):e35508. PubMed ID: 37904484
[TBL] [Abstract][Full Text] [Related]
2. The relationship between ITPA rs1127354 polymorphisms and efficacy of antiviral treatment in Northeast Chinese CHC patients.
Liu Z; Wang S; Qi W; Wang X; Sun D; Wang H; Zhang Y; Li Z; Zhu L; Zhao P; Guo H; Zhou C; Wang J
Medicine (Baltimore); 2017 Jul; 96(29):e7554. PubMed ID: 28723780
[TBL] [Abstract][Full Text] [Related]
3. Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapy.
Amjed S; Saleem HGM; Ullah S; Latif S; Shabana ; Jafar J; Waqar AB
BMC Infect Dis; 2024 Mar; 24(1):301. PubMed ID: 38468199
[TBL] [Abstract][Full Text] [Related]
4. ITPA genetic variants influence efficacy of PEG-IFN/RBV therapy in older patients infected with HCV genotype 1 and favourable IL28B type.
Matsuura K; Tanaka Y; Watanabe T; Fujiwara K; Orito E; Kurosaki M; Izumi N; Sakamoto N; Enomoto N; Yatsuhashi H; Kusakabe A; Shinkai N; Nojiri S; Joh T; Mizokami M
J Viral Hepat; 2014 Jul; 21(7):466-74. PubMed ID: 24750345
[TBL] [Abstract][Full Text] [Related]
5. ITPA polymorphism effects on decrease of hemoglobin during sofosbuvir and ribavirin combination treatment for chronic hepatitis C.
Morio K; Imamura M; Kawakami Y; Nakahara T; Nagaoki Y; Kawaoka T; Tsuge M; Hiramatsu A; Aikata H; Hayes CN; Makokha GN; Ochi H; Amano H; Arataki K; Moriya T; Ito H; Tsuji K; Kohno H; Waki K; Tamura T; Nakamura T; Chayama K;
J Gastroenterol; 2017 Jun; 52(6):746-753. PubMed ID: 27822709
[TBL] [Abstract][Full Text] [Related]
6. Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients.
D'Avolio A; De Nicolò A; Cusato J; Ciancio A; Boglione L; Strona S; Cariti G; Troshina G; Caviglia GP; Smedile A; Rizzetto M; Di Perri G
Antiviral Res; 2013 Oct; 100(1):114-9. PubMed ID: 23933495
[TBL] [Abstract][Full Text] [Related]
7. Relationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysis.
Pineda-Tenor D; García-Álvarez M; Jiménez-Sousa MA; Vázquez-Morón S; Resino S
J Transl Med; 2015 Oct; 13():320. PubMed ID: 26438033
[TBL] [Abstract][Full Text] [Related]
8. Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.
Thompson AJ; Santoro R; Piazzolla V; Clark PJ; Naggie S; Tillmann HL; Patel K; Muir AJ; Shianna KV; Mottola L; Petruzzellis D; Romano M; Sogari F; Facciorusso D; Goldstein DB; McHutchison JG; Mangia A
Hepatology; 2011 Feb; 53(2):389-95. PubMed ID: 21274861
[TBL] [Abstract][Full Text] [Related]
9. Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices.
Di Marco V; Calvaruso V; Grimaudo S; Ferraro D; Pipitone RM; Di Stefano R; Craxì A
J Viral Hepat; 2013 Feb; 20(2):113-21. PubMed ID: 23301546
[TBL] [Abstract][Full Text] [Related]
10. ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C.
El Raziky M; Zayed NA; Abdel Baki A; Mansour SA; Shahin RMH
J Med Virol; 2017 Oct; 89(10):1823-1829. PubMed ID: 28480960
[TBL] [Abstract][Full Text] [Related]
11. Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection.
Seto WK; Tsang OT; Liu K; Chan JM; Wong DK; Fung J; Lai CL; Yuen MF
J Viral Hepat; 2013 Jul; 20(7):470-7. PubMed ID: 23730840
[TBL] [Abstract][Full Text] [Related]
12. A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms.
Alavian SE; Sharafi H; Shirmast P; Alavian SM; Behnava B; Pouryasin M; Keshvari M; Pouryasin A
J Clin Lab Anal; 2018 Sep; 32(7):e22440. PubMed ID: 29660762
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1.
Zhang XH; Cai QX; Hong CX; Lin CS; Zhao ZX
J Med Virol; 2013 Jul; 85(7):1163-9. PubMed ID: 23918534
[TBL] [Abstract][Full Text] [Related]
14. Association of ITPA gene polymorphisms and the risk of ribavirin-induced anemia in HIV/hepatitis C virus (HCV)-coinfected patients receiving HCV combination therapy.
Domingo P; Guardiola JM; Salazar J; Torres F; Mateo MG; Pacho C; Del Mar Gutierrez M; Lamarca K; Fontanet A; Martin J; Muñoz J; Vidal F; Baiget M
Antimicrob Agents Chemother; 2012 Jun; 56(6):2987-93. PubMed ID: 22430973
[TBL] [Abstract][Full Text] [Related]
15. Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirin.
Kurosaki M; Tanaka Y; Tanaka K; Suzuki Y; Hoshioka Y; Tamaki N; Kato T; Yasui Y; Hosokawa T; Ueda K; Tsuchiya K; Kuzuya T; Nakanishi H; Itakura J; Takahashi Y; Asahina Y; Matsuura K; Sugauchi F; Enomoto N; Nishida N; Tokunaga K; Mizokami M; Izumi N
Antivir Ther; 2011; 16(5):685-94. PubMed ID: 21817190
[TBL] [Abstract][Full Text] [Related]
16. Inosine triphosphate pyrophosphatase polymorphisms are predictors of anemia in Chinese patients with chronic hepatitis C during therapy with ribavirin and interferon.
Chi X; Wang M; Pan Y; Jiang J; Jiang T; Yan H; Wu R; Wang X; Gao X; Niu J
J Gastroenterol Hepatol; 2020 Jan; 35(1):97-103. PubMed ID: 31359493
[TBL] [Abstract][Full Text] [Related]
17. Roles of ITPA and IL28B genotypes in chronic hepatitis C patients treated with peginterferon plus ribavirin.
Miyamura T; Kanda T; Nakamoto S; Wu S; Jiang X; Arai M; Fujiwara K; Imazeki F; Yokosuka O
Viruses; 2012 Aug; 4(8):1264-78. PubMed ID: 23012624
[TBL] [Abstract][Full Text] [Related]
18. The impact of inosine triphosphatase variants on hemoglobin level and sustained virologic response of chronic hepatitis C in Korean.
Kim JS; Ahn SM; Jung YK; Kwon OS; Kim YS; Choi DJ; Kim JH
J Korean Med Sci; 2013 Aug; 28(8):1213-9. PubMed ID: 23960450
[TBL] [Abstract][Full Text] [Related]
19. Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapy.
Azakami T; Hayes CN; Sezaki H; Kobayashi M; Akuta N; Suzuki F; Kumada H; Abe H; Miki D; Tsuge M; Imamura M; Kawakami Y; Takahashi S; Ochi H; Nakamura Y; Kamatani N; Chayama K
J Med Virol; 2011 Jun; 83(6):1048-57. PubMed ID: 21503919
[TBL] [Abstract][Full Text] [Related]
20. ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection.
Asselah T; Zeuzem S; Soriano V; Bronowicki JP; Lohse AW; Müllhaupt B; Schuchmann M; Bourlière M; Buti M; Roberts SK; Gane EJ; Stern JO; Voss F; Baum P; Gallivan JP; Böcher WO; Mensa FJ
PLoS One; 2015; 10(12):e0144004. PubMed ID: 26650626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
